Lynside^® Pro GI+. The new probiotic yeast from Lesaffre Human Care, clinically tested on IBS and gut comfort

Lynside^® Pro GI+ is a probiotic yeast, clinically tested for an improved intestinal comfort. The strain used by Lesaffre, Saccharomyces cerevisiae CNCM I-3856, is intended for people suffering from intestinal discomfort such as that caused by Irritable Bowel Syndrome (IBS).

Saccharomyces cerevisiae CNCM I-3856 was selected by Lesaffre amongst 6,000 proprietary strains and has been registered with the French National Collection of Microorganism Cultures (CNCM) under number I-3856.

A patent application covering many different areas has been filed.

Furthermore, many preclinical trials and one large clinical trial have been conducted successfully with the probiotic yeast Lynside^® Pro GI+, and two other clinical trials will have been carried out by end of 2011.

The preclinical trials and the clinical trial on Lynside^® Pro GI+ have led to communications in scientific congresses and publications in international journals.